Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: The FinCV study

Europace

Volumn 15, Issue 10, 2013, Pages 1432-1435

  Grönberg, Toni ^a   Nuotio, Ilpo ^a   Nikkinen, Marko ^b   Ylitalo, Antti ^c   Vasankari, Tuija ^a   Hartikainen, Juha E K ^b   Airaksinen, K E Juhani ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c SATAKUNTA CENTRAL HOSPITAL   (Finland)

Author keywords

Arrhythmic complication; Atrial fibrillation; Bradycardia; Cardioversion

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DISOPYRAMIDE; DRONEDARONE; FLECAINIDE; PROPAFENONE; QUINIDINE;

ADULT; AGE DISTRIBUTION; ARTICLE; ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; CARDIOVERSION; FEMALE; HEART ARREST; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SINUS NODE RECOVERY TIME;

ARRHYTHMIC COMPLICATION; ATRIAL FIBRILLATION; BRADYCARDIA; CARDIOVERSION;

ACUTE DISEASE; AGE FACTORS; AGED; ATRIAL FIBRILLATION; BRADYCARDIA; CARDIAC PACING, ARTIFICIAL; CHI-SQUARE DISTRIBUTION; ELECTRIC COUNTERSHOCK; FEMALE; FINLAND; HEART ARREST; HEART RATE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SINOATRIAL NODE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84884992225     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut106     Document Type: Article

References (23)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5.
2. Lown B, Perlroth MG, Kaidbey S, Abe T, Harken DE. 'Cardioversion' of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients. N Engl J Med 1963; 269:325-31.
3. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart RhythmAssociation. Europace 2012;14:1385-413.
4. Botkin SB, Dhanekula LS, Olshansky B. Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs. Am Heart J 2003;145:233-8.
5. Burton JH, Vinson DR, Drummond K, Strout TD, Thode HC, McInturff JJ. Electrical cardioversion of emergency department patients with atrial fibrillation. Ann Emerg Med 2004;44:20-30.
6. Pisters R, Nieuwlaat R, Prins MH, Le Heuzey JY, Maggioni AP, Camm AJ et al. Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. Europace 2012;14:666-74.
7. Korkeila P, Mustonen P, Koistinen J, Nyman K, Ylitalo A, Karjalainen P et al. Clinical and laboratory risk factors of thrombotic complications after pacemaker implantation: a prospective study. Europace 2010;12:817-24.
8. Airaksinen KE, Biancari F, Karjalainen P, Mikkola R, Kuttila K, Porela P et al. Safety of coronary artery bypass surgery during therapeutic oral anticoagulation. Thromb Res 2011;128:435-9.
9. Annala AP, Karjalainen PP, Biancari F, NiemeläM, Ylitalo A, Vikman S et al. Long-term safety of drug-eluting stents in patients on warfarin treatment. Ann Med 2012;44: 271-8.
10. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:651-745.
11. Ferrer MI. The sick sinus syndrome in atrial disease. JAMA 1968;206:645-6.
12. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008;51:802-9.
13. Kottkamp H. Fibrotic atrial cardiomyopathy: a specific disease/syndrome supplying substrates for atrial fibrillation, atrial tachycardia, sinus node disease, AV node disease, and thromboembolic complications. J Cardiovasc Electrophysiol 2012;23: 797-9.
14. ChangHY, Lin YJ, Lo LW,Chang SL,HuYF, LiCHet al. Sinus node dysfunction in atrial fibrillation patients: the evidence of regional atrial substrate remodelling. Europace 2013;15:205-11.
15. Levy T,Walker S, Rochelle J, Paul V. Evaluation of biatrial pacing, right atrial pacing, and no pacing in patients with drug refractory atrial fibrillation. Am J Cardiol 1999;84: 426-9.
16. Carlson MD, Ip J, Messenger J, Beau S, Kalbfleisch S, Gervais P et al.Anew pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003;42:627-33.
17. Hohnloser SH, Healey JS, Gold MR, IsraelCW, Yang S, van Gelder I et al. Atrial overdrive pacing to prevent atrial fibrillation: insights from ASSERT. Heart Rhythm 2012;9: 1667-73.
18. Scheuermeyer FX, Grafstein E, Stenstrom R, Innes G, Heslop C, Macphee J et al.. Thirty-day and 1-year outcomes of emergency department patients with atrial fibrillation and no acute underlying medical cause. Ann Emerg Med 2012;60:755-65.
19. Xavier Scheuermeyer F, Grafstein E, Stenstrom R, Innes G, Poureslami I, Sighary M. Thirty-day outcomes of emergency department patients undergoing electrical cardioversion for atrial fibrillation or flutter. Acad Emerg Med 2010;17:408-15.
20. Michael JA, Stiell IG, Agarwal S, MandaviaDP. Cardioversion of paroxysmal atrial fibrillation in the emergency department. Ann Emerg Med 1999;33:379-87.
21. Morani G, Cicoira M, Pozzani L, Angheben C, Zanotto G, Vassanelli C. Outpatient electrical cardioversion of atrial fibrillation: 8 years' experience. Analysis of shockrelated arrhythmias. Pacing Clin Electrophysiol 2009;32:1152-8.
22. GallagherMM, Yap YG, Padula M,Ward DE, Rowland E,CammAJ. Arrhythmic complications of electrical cardioversion: relationship to shock energy. Int J Cardiol 2008; 123:307-12.
23. Siaplaouras S, Buob A, Heisel A, BöhmM, Jung J. Outpatient electrical cardioversion of atrial fibrillation: efficacy, safety and patients' quality of life. Int J Cardiol 2005;105: 26-30.